Human Esophageal Smooth Muscle Cells (HESMC)

Human Esophageal Smooth Muscle Cells (HESMC)

Cat.No.: CSC-7781W

Species: Human

Source: Esophagus

Cell Type: Smooth Muscle Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-7781W
Description
Smooth muscle is responsible for the contractility of hollow organs, such as blood vessels, the gastrointestinal tract, the bladder, and the uterus. Its structure differs greatly from that of skeletal muscle. The human esophagus contains three layers of muscle in its walls, the outer longitudinal and inner circular layers of the main muscular coat and the muscular layer of the mucosa. Visceral smooth muscle cells makes up all three layers along the entire organ except for the most rostral few centimeters. Smooth muscle contraction is critical to peristalsis in the human esophagus and the contraction may be mediated by activation of phospholipase through two distinct mechanisms (increased intracellular Ca2+ and G protein activation) and activating PKCepsilon-dependent mechanisms. In vitro study also shows that cultured human esophageal smooth muscle cells express voltage-dependent Na(+) channels.HESMC from Bioarray Research Laboratories are isolated from the human esophagus. HESMC are cryopreserved at secondary culture and delivered frozen. Each vial contains >5 x 10^5 cells in 1 ml volume. HESMC are characterized by immunofluorescent method with antibodies to Α-smooth muscle actin and desmin. HESMC are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HESMC are guaranteed to further expand for 15 population doublings at the condition provided by Bioarray Research Laboratories.
Species
Human
Source
Esophagus
Cell Type
Smooth Muscle Cell
Disease
Normal
Storage and Shipping
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human esophageal smooth muscle cells (HESMC) are primary smooth muscle cells isolated from the human esophageal muscularis propria, typically from the lower esophagus. They retain a contractile, donor-specific phenotype and express canonical smooth muscle markers, including α-smooth muscle actin, SM22α, calponin, desmin, h-caldesmon, and smooth muscle myosin heavy chain. Functionally, HESMC exhibit agonist-induced calcium signaling and contraction, proliferation, migration, and extracellular matrix synthesis. They respond to acetylcholine, KCl, endothelin-1, angiotensin II, serotonin, histamine, and inflammatory cytokines, reflecting native esophageal smooth muscle physiology.

Compared with immortalized smooth muscle lines and animal-derived cells, HESMC better preserve native receptor expression, contractile apparatus, and donor genetic background, improving translational relevance. Because they are human and site-specific, they reduce xenogeneic variability and support personalized studies of esophageal motility disorders and fibrotic remodeling. They are widely used to study esophageal motility, achalasia, gastroesophageal reflux disease, eosinophilic esophagitis, esophageal fibrosis, and tissue-engineered esophageal constructs. They also support drug screening for prokinetic, antispasmodic, anti-inflammatory, and anti-fibrotic agents.

Chronic Hypoxia-Induced Reprogramming of Smooth Muscle Cells

Chronic hypoxia promotes a shift in smooth muscle cells from a quiescent, contractile state to a highly proliferative phenotype, contributing to persistent vascular remodeling. This study examines primary human esophageal smooth muscle cells (HEsSMCs) exposed to hypoxia mimics, desferoxamine (DFO) and dimethyloxallyl glycine (DMOG), and their interaction with angiotensin II (AngII).

The findings indicate that both DFO and DMOG stabilize hypoxia-inducible factor-1 alpha proteins at different time intervals, revealing distinct cell cycle profiles and varied protein responses. DFO was shown to increase mitochondrial reactive oxygen species (ROS) while simultaneously suppressing cytosolic ROS, suggesting the involvement of multiple pathways beyond those activated by hypoxic stress. Flow cytometry analysis revealed that DFO triggers late-stage apoptosis, along with increases in overall hypoxia, ROS, autophagy, lipid peroxidation, and mitochondrial membrane depolarization in HEsSMCs. Furthermore, AngII was observed to inhibit the activation of nuclear factor-κB induced by DFO.

Effects of DFO and DMOG on cytosol and mitochondrial ROS in HEsSMCs.
Fig. 1. Effects of DFO and DMOG on cytosol and mitochondrial ROS in HEsSMCs (Wang, Sheng-Huei, et al., 2026).
Effects of AngII and AngII combined with DFO on target proteins expression, S-phase, and mitochondrial ROS in HEsSMCs.
Fig. 2. Effects of AngII and AngII combined with DFO on target proteins expression, S-phase, and mitochondrial ROS in HEsSMCs (Wang, Sheng-Huei, et al., 2026).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products